| Drug Type Chemical drugs | 
| Synonyms I 1000233, I1000233 | 
| Target | 
| Action inhibitors | 
| Mechanism SHP2 inhibitors(Src homology phosphotyrosyl phosphatase 2 inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Brain metastases | Preclinical | Italy  | 29 Apr 2025 | |
| Brain Cancer | Preclinical | United States  | 22 Mar 2024 | 





